Gabapentin Capsule
Product Images NDC 42385-973

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42385-973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gabapentin Figure1)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The X-axis represents weeks, including a baseline, and is divided into a 4-week dose titration period and a 4-week fixed dose period. The Y-axis displays mean pain scores from 0 to 10. Gabapentin shows a decreasing mean pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure10 (Gabapentin Figure10)

Gabapentin Capsules USP 300 mg packaging label for oral capsules. The label indicates 100 unit-dose capsules in the package, manufactured by Laurus Labs Limited and labeled for Laurus Generics Inc. It includes storage instructions and a medication guide notice. The label uses black text with purple highlights for the strength.*

FDA Label Image

Figure11 (Gabapentin Figure11)

Label for Gabapentin Capsules, USP 400 mg, in a 30-capsule bottle. Manufactured by Laurus Labs Limited and labeled for Laurus Generics Inc. The label includes storage instructions, dispensing guidelines, and a barcode. The product is prescription only.*

FDA Label Image

Figure-12 (Gabapentin Figure12)

Label sheet for Gabapentin Capsule, USP 400 mg, showing multiple identical dose labels. Each label includes the product name, strength (400 mg), 'Rx only' indication, NDC 42385-974-17, manufacturer Laurus Labs Limited, and areas for lot number and expiration date. Barcodes appear on each label.*

FDA Label Image

Figure13 (Gabapentin Figure13)

Gabapentin Capsules, USP 400 mg blister carton label for 100 unit-dose capsules. The label includes dosage strength, manufacturer Laurus Labs Limited, and distributor Laurus Generics Inc. It instructs to dispense the enclosed Medication Guide and notes storage conditions. The label displays the NDC 42385-974-72 and barcode.*

FDA Label Image

Figure 2 (Gabapentin Figure2)

A line graph showing mean pain scores over 7 weeks during a clinical study period, comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The X-axis represents weeks, and the Y-axis shows mean pain scores ranging from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Gabapentin Figure3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' illustrating results from two studies comparing placebo (PBO) and gabapentin (GBP) at various dosages (3600 mg, 1800 mg, 2400 mg). The chart shows responder percentages on the y-axis up to 100%, with gabapentin bars significantly higher than placebo in both studies.*

FDA Label Image

Figure 1 (Gabapentin Figure4)

A scatter plot graph showing the percentage difference versus daily dose in milligrams (mg) for Gabapentin from three studies labeled a, b, and c. The daily doses range from around 600 mg to 1800 mg, with percentage difference values plotted along the vertical axis. Each study is represented by different colored squares: black for Study a, gray for Study b, and white for Study c.*

FDA Label Image

Figure5 (Gabapentin Figure5)

Label for Gabapentin Capsules, USP 100 mg, manufactured by Laurus Labs Limited and Laurus Generics Inc. The label includes dispensing instructions, storage conditions, and packaging details indicating 30 capsules per container. It shows the NDC number 42385-972-30 and manufacturer addresses in India and New Jersey.*

FDA Label Image

Figure-6 (Gabapentin Figure6)

Label sheet for Gabapentin Capsule, USP 100 mg by Laurus Labs Limited. The sheet contains multiple identical labels, each showing the product name, strength (100 mg), route (capsule), Rx only notation, barcode, manufacturer, and placeholders for lot and expiration date. NDC 42385-972-17 is printed on each label.*

FDA Label Image

Figure7 (Gabapentin Figure7)

Gabapentin Capsules, USP 100 mg unit-dose capsules carton for institutional use only. The package contains 100 capsules (10 x 10) and is labeled for dispensing the enclosed medication guide to each patient. Manufactured by Laurus Labs Limited and labeled by Laurus Generics Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Figure8 (Gabapentin Figure8)

Label for Gabapentin Capsules, USP 300 mg, showing package quantity of 30 capsules. The label includes storage instructions, manufacturer Laurus Labs Limited, and distributor Laurus Generics Inc. It displays the NDC 42385-973-30 and advises dispensing the enclosed medication guide to each patient.*

FDA Label Image

Figure9 (Gabapentin Figure9)

Label sheet for Gabapentin Capsule, USP 300 mg by Laurus Labs Limited. The label includes multiple identical rectangular sections each stating "Rx only" with NDC 42385-973-17, the product name Gabapentin Capsule, USP, strength 300 mg in bold on a black background, manufacturer Laurus Labs Limited, and fields for lot and expiration dates. Each section features a barcode. The layout suggests these labels are for individual capsules or bottles.*

FDA Label Image

Structure (Gabapentin Structure)

Chemical structure of Gabapentin showing the arrangement of atoms including an amine group (NH2) and a carboxylic acid group (COOH) attached to a cyclohexane ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.